A latest research reported in Engineering reveals that researchers from Fuzhou University and Hunan Agricultural University have made remarkable ...

Age-related macular degeneration (AMD) primarily affects the elderly, impacting central vision essential for daily activities ...

This is a developing news story. Please check back soon for updates. The FDA approved expanded prescribing information for ...

“The main issue is that at-home devices tend to be underpowered,” said Dr. Tito Vasquez, assistant professor of plastic ...

Choroidal neovascularization (CNV) is one of the most important vision-threatening complications secondary to pathological myopia (PM). In the last 20 years, there have been rapid advances in the ...

PURPOSE: To investigate the correlation between reading speed and scotoma size in patients with subfoveal occult with no classic choroidal neovascularization (CNV) in age-related macular ...

Because the cornea is an avascular, low-cell-density tissue that relies on aqueous humor circulation to maintain metabolism, ...

With the robust demand for personalized medicines and the growing adoption of digital technology, the precision medicine ...

Learn more about whether AbbVie Inc. or Regeneron Pharmaceuticals, Inc. is a better investment based on AAII's A+ Investor ...

Detailed price information for Teva Pharmaceutical Industries ADR (TEVA-N) from The Globe and Mail including charting and trades.

Retinal gene therapy advancements may rewrite the book on treatments for age-related macular degeneration and diabetic eye diseases.

The company’s products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascular ...